Document is current
Any future updates will be listed below
-
Authors
Wolf, Stefan
Madanchi, Matiar https://orcid.org/0000-0001-8396-3977
Turko, Patrick https://orcid.org/0000-0003-3695-8264
Hollmén, Maija https://orcid.org/0000-0002-3250-7653
Tugues, Sonia
von Atzigen, Julia
Giovanoli, Pietro
Dummer, Reinhard https://orcid.org/0000-0002-2279-6906
Lindenblatt, Nicole
Halin, Cornelia https://orcid.org/0000-0002-7899-2850
Detmar, Michael https://orcid.org/0000-0002-5351-5054
Levesque, Mitchell https://orcid.org/0000-0001-5902-9420
Gousopoulos, Epameinondas https://orcid.org/0000-0002-5171-8237
-
Funding
Funding for this research was provided by:
Novartis Stiftung für Medizinisch-Biologische Forschung (22A038)
Sassella Foundation, grant numbers 19/15 JOBST Award
Academy of Finland (316340)
ETH Zurich Open ETH project SKINTEGRITY.CH
- License Information
-
More Information
Article History
Received: 6 September 2023
Accepted: 27 November 2024
First Online: 30 December 2024
Competing interests
: NL acts as Scientific Advisor and Consultant for Medical Microinstruments (MMI). RD has intermittent, project-focused consulting and/or advisory relationships with Novartis, Merck Sharp & Dhome (MSD), Bristol-Myers Squibb (BMS), Roche, Amgen, Takeda, Pierre Fabre, Sun Pharma, Sanofi, Catalym, Second Genome, Regeneron, Alligator, T3 Pharma, MaxiVAX SA, Pfizer, Simcere and touchIME outside the submitted work. All other authors declare that they have no competing interests.
